The gene patenting decision from a plaintiff’s point of view

An overwhelming victory, though details remain uncertain

By Tina Hesman Saey, 16:34 PM June 14, 2013

Arupa Ganguly is pleased with the outcome of her day in court. “I’m ecstatic,” she says. “I feel like a tiger that has been released from a cage.”

Ganguly, who directs the Genetic Diagnostic Laboratory at the University of Pennsylvania’s hospital in Philadelphia, is one of numerous plaintiffs who sued a company called Myriad Genetics over patents the corporation held on genes that raise breast cancer risks. On Thursday the Supreme Court unanimously decided the case in her favor.

In 1995, Gangul...

Source URL:’s-point-view?mode=blog&context=100